Anthropic launches Claude Science for researchers as PwC data shows AI mentions in pharma M&A de

Freedom Capital Markets analyst Gene Mannheimer initiates coverage on Tempus AI (NASDAQ:TEM) with

Tempus receives a Buy rating, leveraging a unique AI-driven diagnostics and data platform with expan

Nancy Pelosi has added stock or options in nine different companies since the start of 2025. A look

 Angiosarcoma is a rare malignant tumor that starts in endothelial cells, which form the inner linin

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption o

The study, titled "Multi-Center Validation of an Artificial Intelligence-Enabled ECG Model to Pr

Ambry Genetics, a leader in clinical genomic testing, and a wholly owned subsidiary of Tempus AI, In

Owkin and Sanofi expand their AI partnership with a five-year deal to develop agentic systems aimed

A selloff in high-flying chipmakers split Wall Street on Thursday, with Broadcom Inc. (NASDAQ:AVGO)‘

Tempus AI (NASDAQ: TEM) stock is surging Thursday after launching a first-of-its-kind open-source di

Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision m

Dell beats massive estimates, IBM launches $5B Project Lightwell, CrowdStrike expands cyber insuranc

Tempus has been building novel biological foundation models and agentic workflows by leveraging its

Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision m

Discover why Tempus AI Inc (NASDAQ:TEM) stock is surging today following major platform expansions a

Ark Invest bought $6.6M in Amazon, $1.2M in Tempus AI, and $218K in Cerebras shares on Wednesday, Ma

Bristol Myers Squibb expands AI efforts through Anthropic and Tempus partnerships as shares edge hig

Tempus AI And Bristol Myers Squibb Expand AI-Driven Trial Design Efforts Across Oncology And Alzheim

Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision m

On Monday, Cathie Wood‘s Ark Invest executed significant trades involving Advanced Micro Devices Inc

HC Wainwright & Co. analyst Yi Chen maintains Tempus AI (NASDAQ:TEM) with a Buy and lowers th

BTIG analyst Mark Massaro maintains Tempus AI (NASDAQ:TEM) with a Buy and lowers the price target

Cathie Wood continued trimming AMD holdings this week, redirecting capital toward Tempus AI amid shi

Tempus also intends to grant the initial purchasers of the Notes an option to purchase, within a 13-

Cathie Wood dumped more AMD on its record rally and pivoted the profits into Tempus AI.

TD Cowen analyst Dan Brennan maintains Tempus AI (NASDAQ:TEM) with a Buy and raises the price tar

Agreement supports the identification of patients eligible for Alzheimer's disease biomarker tes

Tempus AI (TEM) Q1 results: Revenue up 36.1% to $348.1M, beating estimates. TEM raises 2026 outlook

Fresh scrutiny of Nancy Pelosi's market activity follows reports of a roughly $3 million weekly

Tempus AI shares are trading lower after reporting Q1 results. Here are the highlights and the updat

Tempus AI (NASDAQ:TEM) raises FY2026 sales outlook from $1.590 billion to $1.590 billion-$1.600 bill

Tempus AI (NASDAQ:TEM) reported quarterly losses of $(0.13) per share which beat the analyst consens

https://www.wsj.com/pro/venture-capital/fda-turns-to-ai-to-speed-up-clinical-trials-c10d1d

Large-cap stocks surged last week as catalysts from short squeezes to innovation-driven momentum fue

U.S. stocks were mixed at midday Wednesday as tech stocks rallied while industrials dragged the Dow

Tempus AI shares are trading higher Wednesday afternoon after the company announced a collaboration

Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision m

Tempus AI gains as AACR 2026 abstracts highlight biomarkers and cancer subtypes, while Jefferies sta

Jefferies analyst Tycho Peterson initiates coverage on Tempus AI (NASDAQ:TEM) with a Underperform

Tempus AI (TEM) shares up 3.6% on expanded Gilead oncology deal. Explore technical support levels, A

Major U.S. indices closed higher on Thursday, with the Dow Jones Industrial Average up 0.58% at 48,1

Gilead expands Tempus AI deal and licenses Kymera's KT-200, advancing oncology pipeline with dat

Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision m

Tempus AI says ALERT trial shows higher valve procedures and faster care, while analysts keep a Buy

ALERT is the largest known multicenter, cluster-randomized trial to date evaluating an automated EHR

Cathie Wood's Ark Invest bought Tempus AI shares while trimming Meta, signaling a shift toward m

Nancy Pelosi and Jim Cramer are two of the most followed financial personalities. Autopilot tracks t